Method: Shotgun metagenomic sequencing (CLIA 21D2062464); not cleared or approved by the FDA. Results reflect relative microbial abundance for wellness education purposes. Not intended to diagnose or treat disease and not a substitute for clinical consultation. Microbial associations are based on emerging scientific research and may change over time.
A derived biomarker is a value that is calculated from other directly measured biomarkers rather than being measured directly in the lab.
Key benefits of Entamoeba dispar testing
- Non-pathogenic Entamoeba species monitoring
- distinguishing from pathogenic E. histolytica
What is Entamoeba dispar?
Entamoeba dispar is a non-pathogenic amoeba morphologically identical to E. histolytica but without invasive potential. Distinguishing these two species is clinically important. Its detection by shotgun sequencing may help differentiate it from pathogenic E. histolytica carriage. Detected via shotgun metagenomic sequencing.
Why is Entamoeba dispar important?
E. dispar is generally considered non-pathogenic. However, its detection is clinically relevant because it may indicate exposure to fecally contaminated food or water sources, even if this particular species itself causes no harm. Its presence may also co-occur with other pathogens.
What insights will I get?
Your E. dispar result indicates exposure to fecal-oral contamination pathways even in the absence of pathogenic amoeba. This finding may inform hygiene and water quality considerations.
.svg)
.avif)
.avif)
